High Fibroblast Growth Factor 23 as a Biomarker for Severe Cardiac Impairment in Children with Chronic Kidney Disease: A Single Tertiary Center Study.

Retno Palupi-BarotoKristia HermawanIndah Kartika MurniTiara NurlitasariYuli PrihastutiDebora Roselita Karo SekaliCahyani Gita Ambarsari

Published in: International journal of nephrology and renovascular disease (2021)

FGF23 might be used as an early biomarker to detect cardiac changes in pediatric CKD patients, particularly for LVH and impaired systolic function among children with CKD stage 2 and higher.

Keyphrases

chronic kidney disease
end stage renal disease
left ventricular
young adults
peritoneal dialysis
heart failure
blood pressure
ejection fraction
newly diagnosed
prognostic factors
early onset
drug induced